Cysteamine FDA Link

A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.

Also Known As:

Mercaptamine; Cystagon; Hydrochloride, Cysteamine; 2-Aminoethanethiol; Becaptan; Cysteamine Bitartrate; Cysteamine Dihydrochloride; Cysteamine Hydrobromide; Cysteamine Hydrochloride; Cysteamine Maleate (1:1); Cysteamine Tartrate; Cysteamine Tartrate (1:1); Cysteamine Tosylate; Cysteamine, 35S-Labeled; Mercamine; Mercaptoethylamine; beta-Mercaptoethylamine; 2 Aminoethanethiol; 35S-Labeled Cysteamine; Bitartrate, Cysteamine; Cysteamine, 35S Labeled; Dihydrochloride, Cysteamine; Hydrobromide, Cysteamine; Tartrate, Cysteamine; Tosylate, Cysteamine; beta Mercaptoethylamine; Cysteinamine; Ethanethiol, 2-amino-

Pharmalogical Action Categories:

Cystine Depleting Agents

Organic Chemicals: 133
- Amines: 4871
  - Ethylamines: 5
    - Mercaptoethylamines
      - Cysteamine: 1042
- Sulfur Compounds: 278
  - Sulfhydryl Compounds: 4168
    - Mercaptoethylamines
      - Cysteamine: 1042

N- (2- (bis(4- fluorophenyl)methylthio)ethyl)- N- methyl- N- (2- phenyl)ethylamine

Bio-Agent Context: Research Results